vimarsana.com

Page 54 - உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் வழிநடத்தியது News Today : Breaking News, Live Updates & Top Stories | Vimarsana

COVAX has shipped over 36m doses of COVID-19 vaccine to 86 countries: spokesman

COVAX has shipped over 36m doses of COVID-19 vaccine to 86 countries: spokesman Xinhua | Updated: 2021-04-06 11:41 Share   A nurse prepares to administer the AstraZeneca/Oxford vaccine under the COVAX scheme against the coronavirus disease (COVID-19) at the Eka Kotebe General Hospital in Addis Ababa, Ethiopia, March 13, 2021. [Photo/Agencies] UNITED NATIONS - COVAX, a World Health Organization-led initiative aimed at ensuring equal access to COVID-19 vaccines by various countries, has so far shipped more than 36 million doses of COVID-19 vaccines to 86 countries, a UN spokesman said Monday. Algeria received more than 36,000 doses over the weekend from COVAX. These doses will help accelerate the vaccination campaign already underway in the country, Stephane Dujarric, spokesman for UN Secretary-General Antonio Guterres, told the regular press briefing.

COVAX has shipped over 36mn doses to 86 nations

COVAX has shipped over 36mn doses to 86 nations IANS | April 06, 2021 02:45 PM UNITED NATIONS: COVAX, a World Health Organization-led initiative aimed at ensuring equal access to Covid-19 vaccines, has so far shipped more than 36 million doses of the jabs to 86 countries, a UN spokesman said. Algeria received more than 36, 000 doses over the weekend from COVAX. These doses will help accelerate the vaccination campaign already underway in the country, Xinhua news agency quoted Stephane Dujarric, spokesman for UN Secretary-General Antonio Guterres, as saying at a regular press briefing on Monday. He cited Eric Overvest, UN Resident Coordinator in Algeria, as saying that the new doses will help ensure that no one is left behind. Our teams on the ground have helped to train healthcare workers, sensitize people on vaccines, and supported the cold chain .

Covid-19 news: EMA says no verdict yet on AstraZeneca jab review

JOE KLAMAR/AFP via Getty Images Latest coronavirus news as of 5pm on 6 April The EU’s drugs regulator has been investigating reports of rare blood clots in a small number of people who received the vaccine The European Union’s medicines regulator has denied that it has established an association between the Oxford/AstraZeneca covid-19 vaccine and rare blood clots, after an official from the agency claimed it had. Marco Cavaleri, chair of the vaccine evaluation team at the European Medicines Agency (EMA), told Italian newspaper Il Messaggero that there is a “clear” link between the vaccine and an extremely rare blood clot in the brain, but did not provide any evidence to support his claim. In a statement on 6 April, the EMA said it had “not yet reached a conclusion and the review is currently ongoing”, adding that it expected to announce findings from the review on 7 or 8 April. It’s safety committee is investigating 44 reports of cerebral venous sinus thrombosis, a

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.